Projects per year
Fingerprint
Dive into the research topics where Oncology/Hematology is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Michele R Aizenberg Ansari, MD
- Neurosurgery - Associate Professor
- Oncology/Hematology - Courtesy Associate Professor
- Pharmacology & Experimental Neuroscience (PEN) - Courtesy Associate Professor
- Neurosurgery, Nebraska Medicine - Staff Physician
- Fred & Pamela Buffett Cancer Center - Member
Person: Member, Academic, Clinician
-
Zaid S Al-Kadhimi, MD
- Oncology/Hematology - Associate Professor
- Pathology & Microbiology - Courtesy Associate Professor
- Oncology, Nebraska Medicine - Staff Physician
Person: Academic
-
James Olen Armitage, MD
- Oncology/Hematology - Joe Shapiro Chair of Oncology, UNMC Distinguished Cancer Research Professorship, Professor
- Eppley Institute for Cancer Research - Courtesy Professor
- James O Armitage Center for Hematological Malignancies Research - Executive Committee Member
- Fred & Pamela Buffett Cancer Center - Member
- Oncology, Nebraska Medicine - Staff Physician
Person: Member, Academic, Clinician
-
Geranylgeranyl diphosphate synthase inhibitor therapy for multiple myeloma
Holstein, S. A. (PI) & Mohs, A. M. (CoPI)
Project: Research project
-
Aging trajectories and outcomes of older adults with acute myeloid leukemia
Bhatt, V. R. (PI)
Project: Research project
-
Great Plains IDeA-CTR
Guda, B. (CoPI), Klassen, L. W. (CoPI), McClay, J. C. (CoPI), Meza, J. L. (CoPI), Estabrooks, P. A. (CoPI), Philibert, I. (CoPI), Rizzo, M. (CoPI), Cramer, M. E. (CoPI), Rizzo, M. (PI), Holstein, S. A. (CoPI), Rautiainen, R. (CoPI) & Fox, H. S. (CoPI)
Project: Research project
-
3 Things You Should Know About Adverse Events With Targeted Therapies for DLBCL
Lunning, M. & Maddocks, K., Jan 2025, In: Oncology (United States). 39, 1, p. 40-43 4 p.Research output: Contribution to journal › Article › peer-review
-
Academic Community Partnership in Acute Promyelocytic Leukemia and Early Mortality: The ECOG-ACRIN EA9131 Trial
Jillella, A. P., Lee, S. J., Altman, J. K., Luger, S. M., Tallman, M. S., Foran, J. M., Bradshaw, D., Law, L. Y., Bryan, L. J., Abou Zahr, A., Begna, K. H., Perl, A. E., Vadakara, J. J. L., Qamar, R., Bergan, R. C., Fisch, M. J., Carlos, R. C., Wagner, L. I., Kota, V. K. & Litzow, M. R., 2025, (Accepted/In press) In: JAMA Oncology.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
A phase-2 study of pembrolizumab in patients with biologically selected subtypes of relapsed/refractory aggressive lymphomas
Merrill, M. H., Redd, R. A., Fisher, D. C., Abramson, J. S., Barnes, J., Choi, J., Jacobson, C. A., Kim, A. I., Lunning, M. A., Jester, H. D., Jeter, E. L., McDonough, M. M., Armand, P. & Jacobsen, E. D., 2025, (Accepted/In press) In: Leukemia and Lymphoma.Research output: Contribution to journal › Letter › peer-review